Paul T. Winnard, Ph.D. - Publications

2001 The University of Maine, Orono, MN, United States 
Molecular Biology, Biochemistry, Animal Physiology Biology, Zoology Biology

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Winnard PT, Bharti SK, Penet MF, Marik R, Mironchik Y, Wildes F, Maitra A, Bhujwalla ZM. Detection of Pancreatic Cancer-Induced Cachexia Using a Fluorescent Myoblast Reporter System and Analysis of Metabolite Abundance. Cancer Research. 76: 1441-50. PMID 26719527 DOI: 10.1158/0008-5472.CAN-15-1740  0.4
2015 Xie M, Vesuna F, Botlagunta M, Bol GM, Irving A, Bergman Y, Hosmane RS, Kato Y, Winnard PT, Raman V. NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3. Oncotarget. 6: 29901-13. PMID 26337079 DOI: 10.18632/oncotarget.4898  0.4
2014 Winnard PT, Challa R, Bhujwalla ZM, Raman V. Direct facile screening of recombinant DNA vector constructs. Analytical Biochemistry. 450: 1-3. PMID 24393695 DOI: 10.1016/j.ab.2013.12.034  0.4
2013 Chughtai K, Jiang L, Post H, Winnard PT, Greenwood TR, Raman V, Bhujwalla ZM, Heeren RM, Glunde K. Mass spectrometric imaging of red fluorescent protein in breast tumor xenografts. Journal of the American Society For Mass Spectrometry. 24: 711-7. PMID 23184411 DOI: 10.1007/S13361-012-0503-Y  0.4
2013 Jiang L, Greenwood TR, van Hove ER, Chughtai K, Raman V, Winnard PT, Heeren RM, Artemov D, Glunde K. Combined MR, fluorescence and histology imaging strategy in a human breast tumor xenograft model. Nmr in Biomedicine. 26: 285-98. PMID 22945331 DOI: 10.1002/Nbm.2846  0.4
2012 Penet MF, Chen Z, Li C, Winnard PT, Bhujwalla ZM. Prodrug enzymes and their applications in image-guided therapy of cancer: tracking prodrug enzymes to minimize collateral damage. Drug Delivery and Translational Research. 2: 22-30. PMID 23646292 DOI: 10.1007/s13346-011-0052-0  0.4
2012 Jiang L, Greenwood TR, Artemov D, Raman V, Winnard PT, Heeren RM, Bhujwalla ZM, Glunde K. Localized hypoxia results in spatially heterogeneous metabolic signatures in breast tumor models. Neoplasia (New York, N.Y.). 14: 732-41. PMID 22952426 DOI: 10.1593/Neo.12858  0.4
2012 Chen Z, Penet MF, Nimmagadda S, Li C, Banerjee SR, Winnard PT, Artemov D, Glunde K, Pomper MG, Bhujwalla ZM. PSMA-targeted theranostic nanoplex for prostate cancer therapy. Acs Nano. 6: 7752-62. PMID 22866897 DOI: 10.1021/Nn301725W  0.4
2012 Zhang H, Wong CC, Wei H, Gilkes DM, Korangath P, Chaturvedi P, Schito L, Chen J, Krishnamachary B, Winnard PT, Raman V, Zhen L, Mitzner WA, Sukumar S, Semenza GL. HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs. Oncogene. 31: 1757-70. PMID 21860410 DOI: 10.1038/Onc.2011.365  0.4
2011 Penet MF, Winnard PT, Jacobs MA, Bhujwalla ZM. Understanding cancer-induced cachexia: imaging the flame and its fuel. Current Opinion in Supportive and Palliative Care. 5: 327-33. PMID 21986909 DOI: 10.1097/SPC.0b013e32834c49ba  0.4
2011 Botlagunta M, Krishnamachary B, Vesuna F, Winnard PT, Bol GM, Patel AH, Raman V. Expression of DDX3 is directly modulated by hypoxia inducible factor-1 alpha in breast epithelial cells. Plos One. 6: e17563. PMID 21448281 DOI: 10.1371/journal.pone.0017563  0.4
2010 Li C, Penet MF, Wildes F, Takagi T, Chen Z, Winnard PT, Artemov D, Bhujwalla ZM. Nanoplex delivery of siRNA and prodrug enzyme for multimodality image-guided molecular pathway targeted cancer therapy. Acs Nano. 4: 6707-16. PMID 20958072 DOI: 10.1021/nn102187v  0.4
2010 Shah T, Wildes F, Penet MF, Winnard PT, Glunde K, Artemov D, Ackerstaff E, Gimi B, Kakkad S, Raman V, Bhujwalla ZM. Choline kinase overexpression increases invasiveness and drug resistance of human breast cancer cells. Nmr in Biomedicine. 23: 633-42. PMID 20623626 DOI: 10.1002/nbm.1510  0.4
2010 Botlagunta M, Winnard PT, Raman V. Neoplastic transformation of breast epithelial cells by genotoxic stress. Bmc Cancer. 10: 343. PMID 20591176 DOI: 10.1186/1471-2407-10-343  0.4
2010 Satoh H, Moriguchi T, Taguchi K, Takai J, Maher JM, Suzuki T, Winnard PT, Raman V, Ebina M, Nukiwa T, Yamamoto M. Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung. Carcinogenesis. 31: 1833-43. PMID 20513672 DOI: 10.1093/Carcin/Bgq105  0.4
2010 Chen Y, Yuan S, Wierwille J, Naphas R, Li Q, Blackwell TR, Winnard PT, Raman V, Glunde K. Integrated optical coherence tomography (OCT) and fluorescence laminar optical tomography (FLOT) Ieee Journal On Selected Topics in Quantum Electronics. 16: 755-766. DOI: 10.1109/Jstqe.2009.2037723  0.4
2009 Koskimaki JE, Karagiannis ED, Rosca EV, Vesuna F, Winnard PT, Raman V, Bhujwalla ZM, Popel AS. Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts. Neoplasia (New York, N.Y.). 11: 1285-91. PMID 20019836 DOI: 10.1593/Neo.09620  0.4
2009 Chen CW, Blackwell TR, Naphas R, Winnard PT, Raman V, Glunde K, Chen Y. Development of needle-based microendoscopy for fluorescence molecular imaging of breast tumor models Journal of Innovative Optical Health Sciences. 2: 343-352. DOI: 10.1142/S1793545809000747  0.4
2008 Winnard PT, Sukumar S. A PET rat model for assessing the effectiveness of new chemotherapies. Cancer Biology & Therapy. 7: 538-9. PMID 18627116 DOI: 10.4161/Cbt.7.4.5642  0.4
2008 Winnard PT, Botlagunta M, Kluth JB, Mukadam S, Krishnamachary B, Vesuna F, Raman V. Hypoxia-induced human endonuclease G expression suppresses tumor growth in a xenograft model. Cancer Gene Therapy. 15: 645-54. PMID 18551145 DOI: 10.1038/cgt.2008.39  0.4
2008 Winnard PT, Pathak AP, Dhara S, Cho SY, Raman V, Pomper MG. Molecular imaging of metastatic potential. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 96S-112S. PMID 18523068 DOI: 10.2967/Jnumed.107.045948  0.4
2008 Glunde K, Shah T, Winnard PT, Raman V, Takagi T, Vesuna F, Artemov D, Bhujwalla ZM. Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1 alpha signaling in a human prostate cancer model. Cancer Research. 68: 172-80. PMID 18172309 DOI: 10.1158/0008-5472.CAN-07-2678  0.4
2007 Winnard PT, Kluth JB, Kato Y, Artemov D, Raman V. Development of novel chimeric transmembrane proteins for multimodality imaging of cancer cells. Cancer Biology & Therapy. 6: 1889-99. PMID 18059163  0.4
2007 Gilad AA, Winnard PT, van Zijl PC, Bulte JW. Developing MR reporter genes: promises and pitfalls. Nmr in Biomedicine. 20: 275-90. PMID 17451181 DOI: 10.1002/nbm.1134  0.4
2007 Gilad AA, McMahon MT, Walczak P, Winnard PT, Raman V, van Laarhoven HW, Skoglund CM, Bulte JW, van Zijl PC. Artificial reporter gene providing MRI contrast based on proton exchange. Nature Biotechnology. 25: 217-9. PMID 17259977 DOI: 10.1038/nbt1277  0.4
2006 Li C, Winnard PT, Takagi T, Artemov D, Bhujwalla ZM. Multimodal image-guided enzyme/prodrug cancer therapy. Journal of the American Chemical Society. 128: 15072-3. PMID 17117842 DOI: 10.1021/ja066199i  0.4
2006 Raman V, Artemov D, Pathak AP, Winnard PT, McNutt S, Yudina A, Bogdanov A, Bhujwalla ZM. Characterizing vascular parameters in hypoxic regions: a combined magnetic resonance and optical imaging study of a human prostate cancer model. Cancer Research. 66: 9929-36. PMID 17047055 DOI: 10.1158/0008-5472.CAN-06-0886  0.4
2006 Winnard PT, Kluth JB, Raman V. Noninvasive optical tracking of red fluorescent protein-expressing cancer cells in a model of metastatic breast cancer. Neoplasia (New York, N.Y.). 8: 796-806. PMID 17032496 DOI: 10.1593/neo.06304  0.4
2006 Duriseti S, Winnard PT, Mironchik Y, Vesuna F, Raman A, Raman V. HOXA5 regulates hMLH1 expression in breast cancer cells. Neoplasia (New York, N.Y.). 8: 250-8. PMID 16756717 DOI: 10.1593/neo.05766  0.4
2005 Mironchik Y, Winnard PT, Vesuna F, Kato Y, Wildes F, Pathak AP, Kominsky S, Artemov D, Bhujwalla Z, Van Diest P, Burger H, Glackin C, Raman V. Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer. Cancer Research. 65: 10801-9. PMID 16322226 DOI: 10.1158/0008-5472.CAN-05-0712  0.4
2003 Winnard P, Cashon RE, Sidell BD, Vayda ME. Isolation, characterization and nucleotide sequence of the muscle isoforms of creatine kinase from the Antarctic teleost Chaenocephalus aceratus. Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology. 134: 651-67. PMID 12670791 DOI: 10.1016/S1096-4959(03)00025-3  0.4
2002 Winnard P, Sidell BD, Vayda ME. Teleost introns are characterized by a high A+T content. Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology. 133: 155-61. PMID 12381377 DOI: 10.1016/S1096-4959(02)00104-5  0.4
1995 Virzi F, Winnard P, Fogarasi M, Sano T, Smith CL, Cantor CR, Rusckowski M, Hnatowich DJ. Recombinant metallothionein-conjugated streptavidin labeled with 188Re and 99mTc Bioconjugate Chemistry. 6: 139-144. PMID 7711101  0.4
1989 Winnard PT, Esmon CT, Laue TM. The molecular weight and oligomerization of rabbit thrombomodulin as assessed by sedimentation equilibrium Archives of Biochemistry and Biophysics. 269: 339-344. PMID 2537060 DOI: 10.1016/0003-9861(89)90115-X  0.4
Show low-probability matches.